0001610717-24-000235.txt : 20240509
0001610717-24-000235.hdr.sgml : 20240509
20240509160310
ACCESSION NUMBER: 0001610717-24-000235
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240506
FILED AS OF DATE: 20240509
DATE AS OF CHANGE: 20240509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRAMMER ELIZABETH A
CENTRAL INDEX KEY: 0001213041
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36485
FILM NUMBER: 24930339
MAIL ADDRESS:
STREET 1: 78TH FOURTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARDELYX, INC.
CENTRAL INDEX KEY: 0001437402
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 510-745-7047
MAIL ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
FORMER COMPANY:
FORMER CONFORMED NAME: NTERYX INC
DATE OF NAME CHANGE: 20080611
4
1
form4.xml
X0508
4
2024-05-06
0001437402
ARDELYX, INC.
ARDX
0001213041
GRAMMER ELIZABETH A
C/O ARDELYX, INC.
400 FIFTH AVENUE, SUITE 210
WALTHAM
MA
02451
true
See Remarks
false
Common Stock
2024-05-06
4
M
0
110250
0.99
A
378243
D
Common Stock
2024-05-06
4
M
0
109687
2.75
A
487930
D
Common Stock
2024-05-06
4
S
0
64233
8.8714
D
423697
D
Common Stock
2024-05-06
4
S
0
219937
8.877
D
203760
D
Stock Option (Right to Buy)
0.99
2024-05-06
4
M
0
110250
0
D
2032-01-06
Common Stock
110250
85750
D
Stock Option (Right to Buy)
2.75
2024-05-06
4
M
0
109687
0
D
2033-01-05
Common Stock
109687
241313
D
This transaction was executed in multiple trades in prices ranging from $8.63 to $9.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Chief Legal and Administrative Officer
/s/ Elizabeth Grammer
2024-05-09